Basis: Trailing twelve months (TTM). Source: stored company filings and market data; unavailable inputs remain N/A.
The enterprise value (EV) is $613.38M.
ENTERPRISE VALUE (EV)
$613.38M
Candel Therapeutics, Inc.
Market Cap
$731.21M
Enterprise Value (EV)
$613.38M
| NAME | MARKET CAP | ENTERPRISE VALUE (EV) |
|---|---|---|
| Candel Therapeutics, Inc. (CADL) | $731.21M | $613.38M |
| Achieve Life Sciences, Inc. (ACHV)vs › | $732.23M | $699.22M |
| Faeth Therapeutics, Inc. (FTH)vs › | $719.49M | $693.17M |
| Cytek Biosciences, Inc. (CTKB)vs › | $718.28M | $670.89M |
| Avalo Therapeutics, Inc. (AVTX)vs › | $717.44M | $632.30M |
| Design Therapeutics, Inc. (DSGN)vs › | $745.11M | $734.24M |
| Collegium Pharmaceutical, Inc. (COLL)vs › | $712.89M | $1.44B |
| Apnimed, Inc. (APMD)vs › | $750.67M | N/A |
| Mesa Laboratories, Inc. (MLAB)vs › | $760.53M | $831.20M |
| Attovia Therapeutics, Inc. (ATTO)vs › | $763.35M | $734.85M |
Market Cap
$731.21M
Total Debt
$1.90M
Cash
$119.73M
Enterprise Value
$613.38M
Why use EV instead of Market Cap?
Enterprise Value represents the total value of a company as if you were to acquire it completely - paying for equity while assuming debt and receiving cash.
Expanded definitions: Investopedia, Wikipedia, Corporate Finance Institute
